Premium
Phathom Pharmaceuticals Inc (PHAT)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-05-22 | Dr. Asit ParikhIndependent Director | -28,00k | 0,00 | Other Disposition | - | 148,50k | -15,86% |
| 2026-05-20 | Dr. Asit ParikhIndependent Director | 17,50k | 86,63k | Derivative Exercise and Retained Stock | 4,95 | 148,50k | 13,36% |
| 2026-03-10 | Dr. Asit ParikhIndependent Director | -40,00k | 0,00 | Other Disposition | - | 120,50k | -24,92% |
| 2026-02-27 | Robert Charles BreedloveInitié | -1,38k | 17,31k | Sale to Issuer | 12,56 | 55,43k | -2,43% |
| 2026-02-10 | Ms. Anne Marie CookChief Legal Officer & Corporate Secretary | -1,54k | 19,68k | Sale to Issuer | 12,82 | 13,32k | -10,34% |
| 2026-02-10 | Mr. Steven L. BastaCEO, President & Director | -6,28k | 80,47k | Sale to Issuer | 12,82 | 122,28k | -4,88% |
| 2026-01-23 | Dr. Asit ParikhIndependent Director | -80,50k | 0,00 | Other Disposition | - | 120,50k | -40,05% |
| 2026-01-21 | Robert Charles BreedloveInitié | -776,00 | 10,56k | Sale to Issuer | 13,61 | 54,01k | -1,42% |
| 2026-01-13 | Dr. Asit ParikhIndependent Director | 8,75k | 90,13k | Derivative Exercise and Retained Stock | 10,30 | 120,50k | 7,83% |
| 2025-12-19 | Dr. Asit ParikhIndependent Director | 8,75k | 90,13k | Derivative Exercise and Retained Stock | 10,30 | 111,75k | 8,50% |
| 2025-12-18 | Robert Charles BreedloveInitié | -230,00 | 3,74k | Sale to Issuer | 16,28 | 54,79k | -0,42% |
| 2025-12-17 | Ms. Anne Marie CookChief Legal Officer & Corporate Secretary | -7,70k | 118,32k | Sale to Issuer | 15,36 | 9,67k | -44,35% |
| 2025-12-17 | Mr. Steven L. BastaCEO, President & Director | -31,50k | 483,87k | Sale to Issuer | 15,36 | 113,79k | -21,68% |
| 2025-11-28 | Mr. Steven L. BastaCEO, President & Director | 41,63k | 0,00 | Derivative Exercise and Retained Stock | - | 83,25k | 100,00% |
| 2025-11-28 | Mr. Steven L. BastaCEO, President & Director | -48,38k | 755,62k | Derivative Exercise and Sale | 15,62 | 83,25k | - |
| 2025-11-03 | Robert Charles BreedloveInitié | -524,00 | 7,08k | Vente | 13,51 | 54,35k | -0,95% |
| 2025-09-25 | Mr. Steven L. BastaCEO, President & Director | 41,63k | 0,00 | Derivative Exercise and Retained Stock | - | 41,63k | - |
| 2025-09-25 | Mr. Steven L. BastaCEO, President & Director | -48,38k | 564,05k | Derivative Exercise and Sale | 11,66 | 41,63k | - |
| 2025-09-05 | Robert Charles BreedloveInitié | -461,00 | 5,57k | Vente | 12,09 | 54,88k | -0,83% |
| 2025-07-16 | Robert Charles BreedloveInitié | -1,69k | 14,15k | Vente | 8,36 | 53,50k | -3,07% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
